Prions, prionoids and protein misfolding disorders

被引:209
作者
Scheckel, Claudia [1 ]
Aguzzi, Adriano [1 ]
机构
[1] Univ Zurich, Inst Neuropathol, Zurich, Switzerland
基金
欧洲研究理事会; 新加坡国家研究基金会;
关键词
CREUTZFELDT-JAKOB-DISEASE; GLUTAMATE-RECEPTOR; 5; ENDOPLASMIC-RETICULUM STRESS; FATAL FAMILIAL INSOMNIA; GENETIC RISK-FACTORS; A-BETA; ALZHEIMERS-DISEASE; MOUSE MODEL; MUTANT P53; COGNITIVE IMPAIRMENT;
D O I
10.1038/s41576-018-0011-4
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Prion diseases are progressive, incurable and fatal neurodegenerative conditions. The term 'prion' was first nominated to express the revolutionary concept that a protein could be infectious. We now know that prions consist of PrPSc, the pathological aggregated form of the cellular prion protein PrPC. Over the years, the term has been semantically broadened to describe aggregates irrespective of their infectivity, and the prion concept is now being applied, perhaps overenthusiastically, to all neurodegenerative diseases that involve protein aggregation. Indeed, recent studies suggest that prion diseases (PrDs) and protein misfolding disorders (PMDs) share some common disease mechanisms, which could have implications for potential treatments. Nevertheless, the transmissibility of bona fide prions is unique, and PrDs should be considered as distinct from other PMDs.
引用
收藏
页码:405 / 418
页数:14
相关论文
共 196 条
  • [1] Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
    Abeliovich, A
    Schmitz, Y
    Fariñas, I
    Choi-Lundberg, D
    Ho, WH
    Castillo, PE
    Shinsky, N
    Verdugo, JMG
    Armanini, M
    Ryan, A
    Hynes, M
    Phillips, H
    Sulzer, D
    Rosenthal, A
    [J]. NEURON, 2000, 25 (01) : 239 - 252
  • [2] Tau Accumulation Activates the Unfolded Protein Response by Impairing Endoplasmic Reticulum-Associated Degradation
    Abisambra, Jose F.
    Jinwal, Umesh K.
    Blair, Laura J.
    O'Leary, John C., III
    Li, Qingyou
    Brady, Sarah
    Wang, Li
    Guidi, Chantal E.
    Zhang, Bo
    Nordhues, Bryce A.
    Cockman, Matthew
    Suntharalingham, Amirthaa
    Li, Pengfei
    Jin, Ying
    Atkins, Christopher A.
    Dickey, Chad A.
    [J]. JOURNAL OF NEUROSCIENCE, 2013, 33 (22) : 9498 - 9507
  • [3] The prion's elusive reason for being
    Aguzzi, Adriano
    Baumann, Frank
    Bremer, Jullane
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2008, 31 : 439 - 477
  • [4] Mechanisms of disease - Insights into prion strains and neurotoxicity
    Aguzzi, Adriano
    Heikenwalder, Mathias
    Polymenidou, Magdalini
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (07) : 552 - 561
  • [5] Toward Therapy of Human Prion Diseases
    Aguzzi, Adriano
    Lakkaraju, Asvin K. K.
    Frontzek, Karl
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 331 - 351
  • [6] The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids
    Aguzzi, Adriano
    Rajendran, Lawrence
    [J]. NEURON, 2009, 64 (06) : 783 - 790
  • [7] CELL BIOLOGY Beyond the prion principle
    Aguzzi, Adriano
    [J]. NATURE, 2009, 459 (7249) : 924 - 925
  • [8] Cell Biology of Prions and Prionoids: A Status Report
    Aguzzit, Adriano
    Lakkaraju, Asvin K. K.
    [J]. TRENDS IN CELL BIOLOGY, 2016, 26 (01) : 40 - 51
  • [9] Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
    Alexandrova, E. M.
    Yallowitz, A. R.
    Li, D.
    Xu, S.
    Schulz, R.
    Proia, D. A.
    Lozano, G.
    Dobbelstein, M.
    Moll, U. M.
    [J]. NATURE, 2015, 523 (7560) : 352 - +
  • [10] A non-toxic Hsp90 inhibitor protects neurons from Aβ-induced toxicity
    Ansar, Sabah
    Burlison, Joseph A.
    Hadden, M. Kyle
    Yu, Xiao Ming
    Desino, Kelly E.
    Bean, Jennifer
    Neckers, Len
    Audus, Ken L.
    Michaelis, Mary L.
    Blagg, Brian S. J.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) : 1984 - 1990